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Abstract 
Background: Insecticide-based interventions play an integral role in malaria vector control. However, the continued 
spread of insecticide resistance threatens to undermine progress made thus far and may ultimately lead to opera-
tional failure of current control measures. Clothianidin and chlorfenapyr both have unique modes of action and have 
expanded the number of insecticide classes available to vector control programmes. Prior to field use, it is imperative 
to establish their toxicity against local mosquito populations and evaluate potential cross-resistance with other chem-
icals used contemporarily or historically. The aim of this study was to determine the diagnostic doses of clothianidin 
and chlorfenapyr and their efficacies against Anopheles arabiensis, the predominant Ethiopian malaria vector species.
Methods: A range of doses of clothianidin and chlorfenapyr were tested, using modified WHO susceptibility tests 
and CDC bottle bioassays, respectively, against an Ethiopian susceptible laboratory strain and a wild population of An. 
arabiensis collected from Oromia Region, Ethiopia. Cross-resistance to other public health insecticides: carbamates 
(bendiocarb and propoxur), organophosphate (malathion) and pyrethroids (deltamethrin and permethrin), was 
assessed in the same mosquito populations using CDC bottle bioassays.
Results: Complete mosquito mortality was observed with the laboratory strain using the recommended diag-
nostic doses for clothianidin (2%/filter paper) and chlorfenapyr (100 µg/bottle). The field population was resistant 
to malathion (83% mortality), capable of surviving 2×, 5× and 10× the diagnostic dose of both deltamethrin and 
permethrin, but susceptible to bendiocarb and propoxur. The field population of An. arabiensis was significantly more 
susceptible to clothianidin, reaching 100% mortality by day 2 compared to the laboratory strain (100% mortality by 
day 3). In contrast, the wild population was less susceptible to chlorfenapyr, with the highest mortality of 99% at 72 h 
using 200 µg/bottle compared to the laboratory colony, which reached complete mortality at 50 µg/bottle by 24 h.
Conclusions: The putative diagnostic doses of clothianidin and chlorfenapyr are appropriate for monitoring resist-
ance in An. arabiensis from Ethiopia. The unique modes of action and an absence of cross-resistance render clothia-
nidin and chlorfenapyr potential candidates for inclusion in the National Malaria Control Programme vector control 
efforts, particularly in areas with high pre-existing or emergent resistance to other insecticide classes.
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Background
In recent years, substantial achievements have been 
made in global malaria control which has led to an esti-
mated 22% and 29% decrease in malaria incidence and 
mortality, between 2000 and 2015, respectively [1]. These 
impressive achievements have largely resulted from the 
rapid scale-up of diagnosis, treatment and vector con-
trol interventions, particularly indoor residual spraying 
(IRS) and long-lasting insecticidal nets (LLINs). Unfor-
tunately, the expansion of IRS coverage and concomi-
tant mass LLIN distributions have placed high levels of 
selection pressure on Anopheles mosquito populations to 
evolve resistance to the thirteen insecticides belonging 
to the four main classes approved for public health use: 
pyrethroids, carbamates, organophosphates, and organo-
chlorines [2, 3]. Moreover, the rate of decline in malaria 
case incidence has begun to stall and has even reversed 
in some regions since 2014 [4]. Insecticide resistance is 
now a pervasive phenomenon that has been reported 
in approximately two-thirds of countries with ongoing 
malaria transmission [1, 3, 5]. In addition, many vector 
populations are resistant to multiple insecticides from 
different chemical classes; of the 73 countries that pro-
vided monitoring data from 2010 onwards, 50 reported 
resistance to two or more insecticide classes [1]. The 
continued spread of resistance could threaten malaria 
control progress achieved thus far and ultimately lead 
to operational failure of prevailing control measures [3]. 
In response, the current recommendations for insecti-
cide resistance management rely on tactical deployment 
of the active ingredients used for IRS and on LLINs in 
rotation, combinations (particularly LLINs), mosaics and 
mixtures [3, 6]. Unfortunately, these management strate-
gies are restricted in their potential effectiveness by the 
limited choice of available insecticides. The urgent need 
for new chemicals with novel modes of action has been 
the impetus driving the evaluation of established agri-
cultural insecticides to control resistant mosquito vector 
populations [7].
Historically, the chemical industry has not focused 
on the development of new public health insecticides 
because of high market uncertainties and low profit mar-
gins in comparison to the agricultural sector [8, 9]. How-
ever, current efforts are focusing on testing insecticides 
already available to the agricultural industry as poten-
tial public health tools. The ideal insecticide for IRS and 
LLINs should possess the following properties: intrinsic 
toxicity, chemical and physical properties that facilitate 
effective uptake upon contact, long residual efficacy, tox-
icity to specific mosquito species at low dosages, easy 
application to the desired substrate, stability, low volatil-
ity, and low mammalian toxicity (including to other non-
target species). Chlorfenapyr and clothianidin are two 
such insecticides, belonging to different chemical classes 
with distinct modes of action.
Chlorfenapyr is a pyrrole class insecticide commonly 
used against mites and termites, which functions as an 
oxidative phosphorylation uncoupler. This compound 
disrupts the proton gradient across mitochondrial mem-
branes, interrupting ATP synthesis and ultimately result-
ing in death of the organism [10, 11]. A susceptibility 
survey of 19 pesticides tested against insectary colonies 
of Aedes aegypti, Culex quinquefasciatus and Anopheles 
quadrimaculatus indicated that chlorfenapyr was most 
effective against An. quadrimaculatus and least against 
Culex quinquefasciatus [12]; other toxicity screens 
have reported that chlorfenapyr can have a lethal effect 
against field populations of the latter species [13]. Fur-
thermore, multiple phase II trials in Tanzania and Benin 
have highlighted the effectiveness of chlorfenapyr as an 
adjunct to pyrethroid-treated nets against Anopheles ara-
biensis, Anopheles gambiae sensu stricto (s.s.), and Culex 
quinquefasciatus [14–18] and as a candidate for IRS in 
Benin [8, 10].
Clothianidin is one of seven insecticides within the 
neonicotinoid class; it has low mammalian toxicity and is 
primarily used against piercing–sucking insects of major 
crops [19, 20]. The basic mode of action is to target the 
nicotinic acetylcholine receptor (nAChR) in the insect 
central nervous system [19, 21]. Compared with chlo-
rfenapyr, this class of insecticide has been through less 
rigorous study in relation to vector control. At a molecu-
lar level, each neonicotinoid has been characterized by 
differential activity against the nAChR protein subunit 
of An. gambiae, suggesting that these compounds may 
have differential efficacies against target insects [21]. In 
a toxicity survey examining 25 different synthetic insecti-
cides, clothianidin was among the group of six neonicoti-
noids inducing the highest mortality levels against Culex 
quinquefasciatus [13]. Toxicity of six neonicotinoids 
was tested alone and in combination with deltamethrin 
and the synergist piperonyl butoxide (PBO) against Ae. 
aegypti and An. gambiae and all compounds had poor 
individual efficacies but induced higher levels of insec-
ticidal action when in combination, possibly due to the 
amelioration of oxidase and/or esterase activity by PBO 
Keywords: Anopheles arabiensis, Insecticide resistance, Cross-resistance, Clothianidin, Chlorfenapyr, Indoor residual 
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[22]. Clothianidin, both alone and in mixtures, demon-
strated some of the lowest mortality rates among the six 
compounds. However, it is noteworthy that this study 
did not evaluate a range of doses for each insecticide, nor 
monitor mosquito mortality past 24 h; given the slower 
acting nature of these compounds and that each neoni-
cotinoid can produce its own unique range of sub-lethal 
effects, further testing is warranted [22].
Both chlorfenapyr and clothianidin have been manu-
factured into new commercial vector control formula-
tions. Chlorfenapyr is one of two active ingredients in a 
combination LLIN with alpha-cypermethrin, produced 
by BASF  (Interceptor® G2), which received interim 
approval from the World Health Organization (WHO) 
in 2017 [23]. It is also under evaluation as an IRS prod-
uct  (Sylando® 240SC). Clothianidin has been developed 
by Sumitomo into an IRS formulation  (SumiShield® 
50WG), which has been pre-qualified by the WHO [24], 
and Bayer has also incorporated clothianidin in a mixture 
IRS product with deltamethrin (Fludora™ Fusion WP-SB) 
[25]. To date, phase II trials of these respective inter-
ventions have reported promising results with multiple 
resistant vector species [8, 10, 14, 17, 22, 26, 27]. Fur-
thermore, a recent phase III trial in India, demonstrated 
greater reductions in the density of indoor, pyrethroid-
resistant Anopheles culicifacies with  SumiShield® 50WG, 
compared to  Actellic® 300CS (pirimiphos-methyl) [28]. 
Prospective community-level implementation of such 
interventions, as part of National Malaria Control Pro-
grammes (NMCPs), is first predicated on demonstrable 
efficacy against local vector populations.
Insecticide resistance is a major public health concern 
in Ethiopia, where intensive DDT spraying since 1959 
and mass LLIN distributions over the past 10–15  years 
have resulted in highly focal and heterogeneous patterns 
of insecticide resistance across the country [29]. In 2016, 
decreased susceptibility to pyrethroids (alpha-cyper-
methrin, deltamethrin, etofenprox, lambda-cyhalothrin 
and permethrin) and incipient resistance to bendiocarb, 
pirimiphos-methyl and propoxur, the three chemicals 
routinely used for IRS, were detected in multiple regions 
[29]. The aim of this study was to determine the diagnos-
tic doses of chlorfenapyr and clothianidin, defined as the 
concentration of insecticide that kills 100% of susceptible 
mosquitoes within a given time [30], against a susceptible 
laboratory strain of An. arabiensis and screen for resist-
ance in a field-collected multi-resistant An. arabiensis 
population from Oromia region, Ethiopia. Establishment 
of the diagnostic doses will provide a critical starting 
point to monitor future resistance and define the suit-
ability of these insecticides for intervention deployment. 
In addition, improved understanding of the cross-resist-
ance between these novel chemicals and currently used 
insecticides will aid the NMCP and other stakeholders in 
making informed choices regarding the most appropriate 
tools for malaria vector control and insecticide resistance 
management.
Methods
Mosquito strains
Two populations of An. arabiensis were used in this 
study. An insectary-reared strain of An. arabiensis (Debre 
Zeit; DZ) was provided by the Tropical and Infectious 
Diseases Research Center, Jimma University in Sekoru, 
Oromia region  (7o54′50.0″N,  37o25′23.6″E). This strain is 
known to be susceptible to pyrethroid, carbamate, organ-
ochlorine and organophosphate insecticides [31]. Wild 
An. gambiae sensu lato (henceforth referred to as An. 
arabiensis) based on PCR data from local entomological 
surveys conducted between 2012 and 2016) [29, 32] were 
collected as blood-fed adults from inside houses and ani-
mal shelters in Asendabo, Oromia region  (7o40′31″N, 
 36o52′56″E) during the long rainy season in June–August 
2017, and reared at the Jimma University Tropical and 
Infectious Diseases Research Center. Additional field 
sampling for chlorfenapyr testing was undertaken in the 
same area of Asendabo in September 2018.
F1 adults were generated using the forced-oviposition 
method described by Morgan et  al. [33]. Blood-fed, 
field-collected mosquitoes, morphologically identified 
as An. arabiensis [34], were maintained for 4–5  days 
until gravid. Each fully gravid female was transferred to 
a 1.5 ml micro-centrifuge tube containing a slightly wet 
filter paper on top of damp cotton wool and allowed to 
lay eggs. Eggs were pooled to reduce any bias due to fam-
ily effects in larval trays for rearing to the adult stage. 
Previous inferences of genetic diversity estimates in large 
natural populations from finite sample sizes have dem-
onstrated that a sample size of N = 50 field collected 
female mosquitoes was sufficient to capture most genetic 
variation and reduce any family effects on results from  F1 
adults [35]. All life-cycle stages of both laboratory colony 
and wild mosquito populations were maintained under 
standard insectary conditions (25 ± 2  °C, 80% relative 
humidity, light:dark cycles of 12:00  h each) and adults 
were provided with 10% sugar solution.
Clothianidin bioassays
SumiShield 50WG was tested using WHO susceptibility 
tests, with minor modifications to the standard guide-
lines [36].  Whatman® No. 1 filter papers measuring 
12 cm by 15 cm were treated with candidate diagnostic 
doses of SumiShield 50WG (containing 50% clothianidin) 
diluted in distilled water. A stock solution was prepared 
by diluting 264 mg SumiShield 50WG in 20 ml distilled 
water. Two millilitres of the mixed solution was pipetted 
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evenly onto each filter paper and stored at 4 °C until use. 
Filter paper treated with 2 ml of distilled water was used 
as the negative control. Exposure time for clothianidin 
was set at 60 min. Following exposure, mosquitoes were 
transferred to untreated holding tubes and provided with 
lightly moistened cotton wool containing 10% sugar solu-
tion (changed daily). Knock-down was recorded at 30 and 
60 min. Mortality was recorded 1, 2, 3, 4, 5, 6 and 7 days 
after exposure.
Chlorfenapyr and other bioassays
CDC bottle bioassays were conducted according to pub-
lished guidelines [30] and were used to determine the 
diagnostic doses of chlorfenapyr and assess cross-resist-
ance with other insecticides commonly used for vector 
control in Ethiopia. Each Wheaton 250 ml bottle and its 
cap was coated with 1 ml of insecticide solution by roll-
ing and inverting the bottles. In parallel, a control bottle 
was coated with 1 ml of acetone, following which all bot-
tles were covered with a sheet and left to dry in the dark. 
Mosquitoes were exposed to chlorfenapyr for 60 min and 
all other insecticides (bendiocarb, deltamethrin, mala-
thion, permethrin and propoxur) for 30  min. Following 
exposure, mosquitoes were transferred to a paper cup 
covered with untreated netting, provided with lightly 
moistened cotton wool containing 10% sugar solution 
(changed daily) and monitored at 24  h, 48  h, and 72  h. 
Knock-down was recorded at 30  min (all other insec-
ticides) or 60  min (chlorfenapyr) and mortality at 24  h, 
48 h and 72 h after exposure.
Diagnostic dose determination
A diagnostic dose is defined as the dose of insecticide 
that kills 100% of susceptible mosquitoes within a defined 
period of time [30]. Based on guidance from Sumitomo 
Corporation and the Africa Indoor Residual Spraying 
program (AIRS), a diagnostic dose of 2% w/v clothia-
nidin (13.2 mg active ingredient per paper, equivalent to 
734  mg ai/m2) was recommended (unpublished data). 
Doses tested for clothianidin in this study were 0.0625 
0.125, 0.25, 0.5, 1, and 2%. Previous evaluations con-
ducted by the CDC identified 100 µg/bottle as a putative 
reference diagnostic dose for chlorfenapyr (unpublished 
data). In this study, a range of lower and higher doses 
were tested in bottle bioassays: 0.78125, 1.5625, 3.125, 
6.25, 12.5, 25, 50, 100, and 200 µg/bottle.
Bioassays to determine the diagnostic doses of clo-
thianidin and chlorfenapyr were conducted using both 
DZ and  F1 generation wild mosquitoes. Multiple batches 
of 20–25 unfed, 2–5  days old, female mosquitoes were 
exposed to each dose of insecticide. All bioassays were 
conducted in temperatures of 27 ± 3  °C with relative 
humidity of 75–85%.
Cross‑resistance testing
Levels of susceptibility to carbamate (bendiocarb and 
propoxur), organophosphate (malathion) and pyrethroid 
(deltamethrin and permethrin) insecticides were assessed 
among the same population of field-collected mosqui-
toes. Multiple batches of 20–25 unfed, 2–5  day old  F1 
mosquitoes were exposed for 30 min to technical grade 
permethrin (21.5  µg/bottle), deltamethrin, bendiocarb 
and propoxur (all 12.5 µg/bottle) and malathion (50 µg/
bottle) in CDC bottle bioassays and knock-down/mortal-
ity scored every 15 min for up to 2 h [30]. For bendiocarb, 
deltamethrin and permethrin, additional bioassays were 
conducted with two, five and ten times the diagnostic 
dose [30].
Data analysis
Generalized linear mixed models were fit to replicate 
data to estimate the mean mortality proportion when 
comparing exposed and control female An. arabiensis DZ 
colony mosquitoes to evaluate putative diagnostic doses 
of clothianidin and wild An. arabiensis to test differ-
ent doses of chlorfenapyr [37]. Random intercepts were 
included in these models for each batch of mosquitoes 
tested. These comparisons utilize model-based estimates 
and post hoc contrast statements to compare exposed 
and control mosquitoes. In all other evaluations, mod-
els did not achieve convergence largely due to a lack of 
variability between replicates. For these evaluations, rep-
licates are aggregated and evaluated using Pearson’s Chi-
squared test or, when the expected number of events in a 
cell fell below 5, Fisher’s Exact test and odds ratios were 
calculated using the conditional maximum likelihood. 
All phenotypic data were interpreted according to the 
WHO guidelines: mortality of 98% or higher indicates 
susceptibility, mortality of 90–97% is suggestive of resist-
ance and mortality of less than 90% indicates resistance 
[36]. Because mortality of control mosquitoes for chlor-
fenapyr, carbamates, organophosphates and pyrethroids 
consistently fell below 5%, Abbott’s formula was not 
required to correct mortality. Given the extended hold-
ing period for clothianidin, bioassay data were not dis-
carded if control mortality was greater than 20% by day 3; 
control data are reported in parallel with test replicates. 
Analyses were performed in R version 3.5.1 [38], with the 
level of significance set at α = 0.05.
Results
Diagnostic dose determination: clothianidin
A total of 1,265 female An. arabiensis DZ colony (n = 855 
exposed and n = 410 control) (Fig.  1) and 177 wild An. 
arabiensis (n = 132 exposed and n = 45 control) (Fig.  2) 
mosquitoes were used to evaluate putative diagnostic 
doses of clothianidin. Complete mosquito mortality was 
Page 5 of 11Dagg et al. Malar J           (2019) 18:49 
observed at 2% clothianidin in both the wild and labora-
tory strains at 2 and 3  days post-exposure, respectively. 
Knock-down at both 30  min (wild: 19%; 25/132 vs. DZ: 
1%; 2/200, OR = 23.13, CI 4.38–122.29, p < 0.0001) 
and 60  min (wild: 45%; 60/132 vs. DZ: 8%; 15/200, 
OR = 10.28, CI 5.02–21.04, p < 0.0001) was significantly 
higher in the wild population compared to the suscepti-
ble strain. Results from both knock-down rates and time 
to 100% mortality indicate that the wild population was 
more susceptible to 2% clothianidin, compared to the 
laboratory DZ strain.  
Apart from 2%, no other tested clothianidin concen-
tration achieved 100% mortality with the DZ strain by 
the end of the 7-day holding period. As expected, a clear 
decrease in toxicity was observed as the insecticide con-
centration was reduced. Mortality to insecticide doses 
below 0.125% were not significantly different to that of 
the controls by day 7 (OR = 1.92, CI 0.78–4.71, p = 0.16 
at 0.0625%). Controls for all tests were maintained for the 
7-day holding period, even if test replicates reached 100% 
mortality before this cut-off. By day 7, the majority of 
control replicates had a mortality rate > 20%; mean mor-
tality of DZ and wild mosquitoes at day 7 was 31% and 
27%, respectively (Figs. 1, 2).
Diagnostic dose determination: chlorfenapyr
A total of 840 female An. arabiensis DZ colony mosqui-
toes (n = 701 exposed and n = 139 control) (Fig.  3) and 
500 wild An. arabiensis (n = 400 exposed and n = 100 
control) (Fig. 4) were used to test different doses of chlo-
rfenapyr. For the DZ colony strain, the putative diagnos-
tic dose of 100 μg/bottle was confirmed to produce 100% 
mortality after 24 h. Complete mortality within 24 h was 
also observed at 50  μg/bottle and for 25  μg/bottle after 
48 h, indicating that a lower dose may be equally effective 
at controlling this laboratory population. A reduction 
in dose response after 24 h started at 25 μg/bottle (96% 
mortality; 92/96) and steadily declined with decreasing 
concentration (Fig. 3). Complete mortality by 72 h was no 
longer observed at 12.5 μg/bottle (99% mortality; 87/88). 
By comparison, complete mortality was not observed 
with wild An. arabiensis for any dose within 72  h, 
Fig. 1 Estimated proportion mortality and 95% confidence intervals from generalized linear mixed models for days 1 through 7 post-exposure of 
the susceptible DZ Anopheles arabiensis strain exposed to six doses of clothianidin or a negative control in WHO susceptibility tests. Doses ranged 
between 0.0625 and 2%
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suggesting that a higher concentration or longer hold-
ing period is required to kill this population. For the rec-
ommended diagnostic dose of 100  μg/bottle, mortality 
peaked at 98% (78/80) after 72 h and the highest rate was 
observed at 200 μg/bottle after 72 h (99%; 79/80). In com-
parison to the DZ strain, the wild population produced a 
more pronounced reduction in response following each 
subsequent decrease in concentration (Fig.  4). There 
was no significant difference in mean mosquito mortal-
ity between the susceptible and wild strains at 24 h, 48 h, 
and 72  h for doses of 100  μg/bottle (Fisher’s Exact test, 
OR = 0, CI 0–1.76, p = 0.07; OR = 0, CI 0–1.76, p = 0.07; 
and OR = 0, CI 0–3.89, p = 0.18 at 24  h, 48  h and 72  h, 
respectively) and at 48  h and 72  h for doses of 200  μg/
bottle (Fisher’s Exact test, OR = 0, CI 0–1.98, p = 0.09; 
and OR = 0, CI 0–32.17, p = 0.45 at 48 h and 72 h, respec-
tively; OR = 0, CI 0–0.88, p = 0.02 at 24 h). However, sig-
nificant differences in survival between the susceptible 
and wild strains were observed at dose 50 μg/bottle start-
ing at 24 h (p < 0.0001).
Cross‑resistance testing
A total of 1132 wild female An. arabiensis (955  F0 and 
177  F1 generation) were used to assess susceptibility 
and cross-resistance to key public health insecticides 
routinely used in Ethiopia (Fig.  5). Among this wild 
population, moderate to intense pyrethroid resistance 
was evident, with proportions of mosquitoes capable 
of surviving two, five and ten times the diagnostic dose 
of deltamethrin and permethrin (Fig.  5). In addition, 
decreased susceptibility to the organophosphate mala-
thion was observed (average mosquito mortality of 83%). 
Fig. 2 Proportion mortality of wild Anopheles arabiensis exposed to 
2% clothianidin and controls in WHO susceptibility tests. Knock-down 
is presented for 30 and 60 min and mortality for days 1–7 
post-exposure (with 95% confidence intervals using Wilson’s formula 
with Yates’ continuity correction)
Fig. 3 Proportion mortality of the susceptible DZ Anopheles arabiensis strain exposed to nine doses of chlorfenapyr using CDC bottle bioassays 
and control replicates. Doses ranged between 0.78125 and 200 μg/bottle. Mortality is presented for 24, 48 and 72 h post-exposure (with 95% 
confidence intervals using Wilson’s formula with Yates’ continuity correction)
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Fig. 4 Estimated proportion mortality and 95% confidence intervals from generalized linear mixed models of wild Anopheles arabiensis exposed to 
five doses of chlorfenapyr using CDC bottle bioassays. Doses ranged between 12.5 and 200 μg/bottle. Mortality is presented for 1, 2, 24, 48 and 72 h 
post-exposure. Control mortality in all assays was 0%
Fig. 5 Mean percent mortality of wild Anopheles arabiensis exposed to one, two, five or ten times the diagnostic doses of pyrethroids (deltamethrin 
and permethrin) and the diagnostic doses of carbamates (bendiocarb and propoxur) and organophosphate (malathion) insecticides. Mortality is 
presented for 30 min post-exposure (with 95% confidence intervals)
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No resistance was detected to either carbamate insecti-
cide evaluated (bendiocarb or propoxur); 100% mosquito 
mortality was achieved within 15 min of exposure. For all 
bioassays, mortality was recorded for a total of 120 min. 
For both deltamethrin and permethrin, mosquitoes con-
tinued to survive past 30 min of exposure to ten times the 
diagnostic dose (+15 min, 1/81 alive for permethrin and 
+45  min, 4/54 alive for deltamethrin) but all replicates 
reached 100% mortality by 2 h. Similarly, for malathion, 
all survivors died within 15 min past the exposure period 
(total 45 min).
Discussion
Given the limited number of insecticides available for 
public health use, there is an urgent need to evaluate 
alternate chemicals with new modes of action to improve 
the control of resistant vector populations [7]. This study 
determined the diagnostic doses of clothianidin (neoni-
cotinoid) and chlorfenapyr (pyrrole) for resistance moni-
toring of field populations of An. arabiensis in Ethiopia 
and also investigated the prevalence of cross-resistance 
to other chemicals already in use by the NMCP. Diagnos-
tic doses for chlorfenapyr at 100  µg/bottle and clothia-
nidin at 2%/filter paper (both using 60  min exposures) 
against the susceptible laboratory-reared An. arabien-
sis DZ strain achieved complete mortality by 24  h and 
72 h, respectively. These testing conditions are therefore 
appropriate for this laboratory population and can be 
used to screen for susceptibility to these compounds in 
the field, as well as to monitor residual efficacy of inter-
ventions longitudinally.
By comparison, field collected An. arabiensis exposed 
to 2%/filter paper clothianidin, demonstrated signifi-
cantly higher rates of knock-down at 30 and 60 min and 
reached 100% mortality 24 h earlier than the laboratory 
DZ strain. It is conceivable that this increased suscep-
tibility may result from a fitness cost or negative cross-
resistance incurred by the presence of other resistance 
traits. A similar phenomenon has been described for the 
neonicotinoid, dinotefuran, which was more toxic against 
carbamate-resistant Culex quinquefasciatus, compared 
to a susceptible strain, in both larval bioassays and topical 
applications to adults [39]. These results were attributed 
to insensitive acetylcholinesterase being less efficient at 
degrading nicotinic substrates, such that in the presence 
of dinotefuran, the concentration of acetylcholine could 
increase more rapidly at the synaptic level in carbamate 
resistant individuals, leading to earlier saturation of nico-
tinic receptors and higher levels of mortality [39]. Addi-
tional laboratory studies have reported that an Anopheles 
stephensi colony which was resistant to DDT, malathion 
and deltamethrin, required lower lethal concentra-
tions of the neonicotinoids imidacloprid, thiacloprid 
and thiamethoxam, compared to a susceptible counter-
part [40], while a tri-mixture of PBO, deltamethrin and 
dinotefuran was more effective than a combination of 
PBO and deltamethrin in killing a pyrethroid resistant 
An. gambiae strain (VKPR: homozygous for kdr) [26]. In 
the latter case, it was proposed that PBO blocked mixed-
function oxidase (MFO) detoxification of deltamethrin, 
allowing the rate of miniature excitatory postsynaptic 
potentials and resulting acetylcholine release to increase, 
with dinotefuran competitively inhibiting the inactiva-
tion of nicotinic receptors.
In the present study, additional testing demonstrated 
that the wild An. arabiensis population had higher toler-
ance to the organophosphate malathion as well as intense 
resistance to the pyrethroids deltamethrin and perme-
thrin, with survivors at five and ten times the diagnostic 
insecticide dose. Complete susceptibility to the carba-
mates bendiocarb and propoxur was also observed. This 
field population has previously been characterized by 
moderate L1014F kdr allele frequencies, an absence of the 
G119S-Ace-1R mutation and partial synergism to pyre-
throids following PBO exposure [29, 32, 41]. To date, the 
underlying metabolic mechanisms conferring resistance 
to organophosphates and pyrethroids await elucidation 
but the putative negative cross-resistance to clothianidin 
render this insecticide a promising candidate for inclu-
sion in local vector control campaigns.
The efficacy of chlorfenapyr against resistant mosquito 
species has been reported from multiple settings [8, 10, 
11, 15–18, 32, 42–47]. Because the mode of action for 
chlorfenapyr differs from that of other neurotoxic insecti-
cides used for malaria vector control, it is anticipated that 
there is minimal risk for cross-resistance to evolve from 
currently known metabolic resistance pathways [18]. 
Furthermore, laboratory studies have demonstrated that 
PBO can act as an antagonist with chlorfenapyr, reducing 
mosquito mortality, owing to the involvement of MFOs 
in the initial conversion step of the pro-insecticide to its 
active toxic form [11, 48, 49]. This property highlights the 
potential of this insecticide to manage resistant popula-
tions characterized by elevated oxidases, one of the pre-
dominant mechanisms conferring insecticide resistance 
across sub-Saharan Africa [50]. However, in this study, 
complete mortality was not achieved with the wild An. 
arabiensis population at any dose within 72 h indicating 
that a higher concentration or longer holding period may 
be required. Previous laboratory evaluations have high-
lighted temperature and time of bioassay, as two factors 
which can influence mortality; activation of chlorfenapyr 
and disruption of respiratory pathways is enhanced when 
the mosquito is more metabolically and behaviourally 
active [51]. All of the current testing was conducted dur-
ing the daytime, at constant, regulated temperatures, 
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which may account for lower levels of lethality; in this 
dataset it is not possible to ascribe incomplete mortality 
to this scenario or the presence of a small proportion of 
more tolerant individuals. Study findings reinforce the 
need to adapt standardized laboratory testing guidelines 
to take into account the idiosyncrasies of non-neurotoxic 
insecticides [44, 51].
During testing, a number of limitations were encoun-
tered and areas of improvement were identified. Due to 
issues of crystallization and achieving uniform coating 
of Wheaton bottles with technical grade clothianidin 
diluted in acetone, formulated SumiShield 50WG was 
used to treat filter papers for WHO susceptibility tests. In 
addition to introducing batch variability between ‘home-
made’ filter papers, other additives contained within this 
formulation may have also contributed an unmeasurable 
degree toward mosquito mortality. In future studies, it 
may be appropriate to evaluate alternate methodologies 
and solvents to facilitate the use of technical grade insec-
ticide in bioassays. In the clothianidin bioassays, main-
taining control mosquitoes for 7  days presented issues, 
with mortality exceeding 20% by day 5 in a number of 
replicates, possibly because of old age or starvation due 
to a lack of blood meal. Given that complete mortality 
in both wild and field populations was achieved within 
3  days, longer holding periods may not be needed for 
future testing of these particular populations. The clo-
thianidin results have been interpreted relative to reports 
of other neonicotinoids; however, observations may not 
be generalizable as each compound is known to vary in 
binding potency to the nAChR receptor and may, there-
fore, exert distinct effects between insect species [21]. 
Unfortunately, due to insufficient sampling, the wild An. 
arabiensis used in chlorfenapyr testing was not collected 
at the same time as those used to assess the diagnostic 
doses of clothianidin or other insecticides, preventing 
complete comparisons between these groups. However, 
the resistance profiles of this population have been shown 
to be consistent over the last couple of years [29]. Finally, 
levels of insecticide resistance of wild Ethiopian mosqui-
toes are highly focal and heterogenous across the country 
[29, 41] and ideally such screening (including different 
concentrations and exposure times) and cross-resistance 
testing would be extended to other field populations with 
different resistance intensities and underlying molecular 
and metabolic mechanisms. Future studies may also con-
sider including synergists to explore possible metabolic 
mechanisms that can explain the observed cross-resist-
ance, especially for clothianidin which is known to have 
a synergistic effect with PBO [22, 26]. This work only 
examined lethal effects of exposure, while some neoni-
cotinoids are known to modify insect behaviour at suble-
thal concentrations; if these compounds impact feeding 
behaviour, fecundity and/or egg hatchability, these could 
also be important contributors to reducing vectorial 
capacity. The range of sub-lethal concentrations iden-
tified herein provide potential starting points for such 
studies.
Conclusions
This study demonstrated that the putative diagnostic 
doses of clothianidin and chlorfenapyr are appropriate 
for monitoring resistance in An. arabiensis from Ethio-
pia. The unique slower acting modes of action of clothi-
anidin and chlorfenapyr have been predicted to impose 
less selection pressure for the evolution of insecticide 
resistance compared to faster acting chemicals [52]. Cou-
pled with the absence of cross-resistance (and potential 
occurrence of negative cross-resistance) to insecticides 
in current use for malaria control in Ethiopia, vector 
control interventions incorporating clothianidin and 
chlorfenapyr warrant consideration for inclusion in the 
National Malaria Control Programme resistance manage-
ment strategy, particularly in areas with high pre-existing 
or emergent resistance to multiple insecticide classes.
Authors’ contributions
KA, SI, DY and LAM designed the study and were responsible for data analysis 
and interpretation. REW provided statistical expertise during data analysis. JS 
and DY coordinated entomological collections and provided materials and 
equipment. KD, SI, REW and LAM drafted the manuscript which was revised by 
co-authors. All authors read and approved the final manuscript.
Author details
1 Faculty of Infectious Tropical Diseases, London School of Hygiene and Tropi-
cal Medicine, London, UK. 2 Entomology Branch, Centers for Disease Control 
and Prevention, 1600 Clifton Road, Atlanta, GA 30329-4027, USA. 3 President’s 
Malaria Initiative, Bureau for Global Health, Office of Infectious Disease, United 
States Agency for International Development, Washington, DC, USA. 4 Presi-
dent’s Malaria Initiative Africa Indoor Residual Spraying Project, Abt Associates, 
Gerji Road, Sami Building 1st Floor, Addis Ababa, Ethiopia. 5 Tropical and Infec-
tious Diseases Research Center, Jimma University, Jimma, Ethiopia. 6 Depart-
ment of Medical Laboratory Sciences and Pathology, College of Health Sci-
ences, Jimma University, Jimma, Ethiopia. 7 American Society for Microbiology, 
1752 N Street, NW, Washington, DC 20036, USA. 
Acknowledgements
The authors would like to thank all mosquito collectors for their dedicated 
work and the residents of Asendabo.
Competing interests
The authors declare that they have no competing interests.
Availability of data and materials
Not applicable.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Wild mosquitoes used for this study were collected from dwellings and 
animal houses, following homeowners’ written consent. The study protocol 
was reviewed and approved by the institutional review boards (IRBs) of the 
College of Health Sciences at Jimma University (THRPGD/843/17), the Centers 
for Disease Control and Prevention, USA (2017-227) and the London School 
of Hygiene and Tropical Medicine (#12224). The findings and conclusions 
Page 10 of 11Dagg et al. Malar J           (2019) 18:49 
in this paper are those of the authors and do not necessarily represent the 
official position of the Centers for Disease Control (CDC) and Prevention or the 
American Society for Microbiology (ASM).
Funding
This study was funded by the Bayer Research and Travel Grant for Vector 
Control Research and the Gilchrist Educational Trust, awarded to KD and a 
L’Oreal-UNESCO for Women in Science UK and Ireland Fellowship awarded to 
LAM. LAM is supported by an American Society for Microbiology/Centers for 
Disease Control and Prevention Fellowship. SI is supported by the President’s 
Malaria Initiative (PMI)/CDC.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
Received: 26 November 2018   Accepted: 14 February 2019
References
 1. WHO. World malaria report 2016. Geneva: World Health Organization; 
2016.
 2. Mnzava AP, Knox TB, Temu EA, Trett A, Fornadel C, Hemingway J, et al. 
Implementation of the global plan for insecticide resistance manage-
ment in malaria vectors: progress, challenges and the way forward. Malar 
J. 2015;14:173.
 3. WHO. Global plan for insecticide resistance management. Geneva: World 
Health Organization; 2012.
 4. WHO. World malaria report 2017. Geneva: World Health Organization; 
2017.
 5. Corbel V, Guessan RN. Anopheles mosquitoes—new insights into malaria 
vectors. In: Manguin S, editor. Anopheles mosquitoes—new insights into 
Malar vectors. Rijeka: InTech; 2013. p. 579–633.
 6. Denholm I, Rowland M. Tactics for managing pesticide resistance in 
arthropods: theory and practice. Annu Rev Entomol. 1992;37:91–112.
 7. Hemingway J, Beaty BJ, Rowland M, Scott TW, Sharp BL. The Innova-
tive Vector Control Consortium: improved control of mosquito-borne 
diseases. Trends Parasitol. 2006;22:308–12.
 8. Oxborough RM, Kitau J, Matowo J, Mndeme R, Feston E, Boko P, et al. 
Evaluation of indoor residual spraying with the pyrrole insecticide 
chlorfenapyr against pyrethroid-susceptible Anopheles arabiensis and 
pyrethroid-resistant Culex quinquefasciatus mosquitoes. Trans R Soc Trop 
Med Hyg. 2010;104:639–45.
 9. Hoppé M, Hueter OF, Bywater A, Wege P, Maienfisch P. Evaluation of com-
mercial agrochemicals as new tools for malaria vector Control. Chim Int J 
Chem. 2016;70:721–9.
 10. Ngufor C, Critchley J, Fagbohoun J, N’Guessan R, Todjinou D, Rowland M, 
et al. Chlorfenapyr (a pyrrole insecticide) applied alone or as a mixture 
with alpha-cypermethrin for indoor residual spraying against pyrethroid 
resistant Anopheles gambiae s.l.: an experimental hut study in Cove, Benin. 
PLoS ONE. 2016;11:e0162210.
 11. Raghavendra K, Barik TK, Sharma P, Bhatt RM, Srivastava HC, Sreehari U, 
et al. Chlorfenapyr: a new insecticide with novel mode of action can 
control pyrethroid resistant malaria vectors. Malar J. 2011;10:16.
 12. Pridgeon JW, Pereira RM, Becnel JJ, Allan SA, Clark GG, Linthicum KJ. 
Susceptibility of Aedes aegypti, Culex quinquefasciatus Say, and Anopheles 
quadrimaculatus Say to 19 pesticides with different modes of action. J 
Med Entomol. 2008;45:82–7.
 13. Shah RM, Alam M, Ahmad D, Waqas M, Ali Q, Binyamin M, et al. Toxicity of 
25 synthetic insecticides to the field population of Culex quinquefasciatus 
Say. Parasitol Res. 2016;115:4345–51.
 14. Mosha FW, Lyimo IN, Oxborough RM, Malima R, Tenu F, Matowo J, et al. 
Experimental hut evaluation of the pyrrole insecticide chlorfenapyr on 
bed nets for the control of Anopheles arabiensis and Culex quinquefascia-
tus. Trop Med Int Health. 2008;13:644–52.
 15. N’Guessan R, Boko P, Odjo A, Knols B, Akogbeto M, Rowland M, 
et al. Control of pyrethroid-resistant Anopheles gambiae and Culex 
quinquefasciatus mosquitoes with chlorfenapyr in Benin. Trop Med Int 
Health. 2009;14:389–95.
 16. Oxborough RM, Kitau J, Matowo J, Feston E, Mndeme R, Mosha FW, et al. 
ITN mixtures of chlorfenapyr (pyrrole) and alphacypermethrin (pyre-
throid) for control of pyrethroid resistant Anopheles arabiensis and Culex 
quinquefasciatus. PLoS ONE. 2013;8:e55781.
 17. N’Guessan R, Ngufor C, Kudom AA, Boko P, Odjo A, Malone D, et al. Mos-
quito nets treated with a mixture of chlorfenapyr and alphacypermethrin 
control pyrethroid resistant Anopheles gambiae and Culex quinquefascia-
tus mosquitoes in West Africa. PLoS ONE. 2014;9:e87710.
 18. N’Guessan R, Boko P, Odjo A, Akogbéto M, Yates A, Rowland M. Chlo-
rfenapyr: a pyrrole insecticide for the control of pyrethroid or DDT 
resistant Anopheles gambiae (Diptera: Culicidae) mosquitoes. Acta Trop. 
2007;102:69–78.
 19. Tomizawa M, Casida JE. Mechanisms of selective action. Annu Rev Phar-
macol Toxicol. 2005;45:247–68.
 20. Simon-Delso N, Amaral-Rogers V, Belzunces LP, Bonmatin JM, Chagnon 
M, Downs C, et al. Systemic insecticides (neonicotinoids and fipronil): 
trends, uses, mode of action and metabolites. Environ Sci Pollut Res. 
2015;22:5–34.
 21. Elamathi N, Verma V, Sharma P, Uragayala S, Kamaraju R. Neonicotinoids in 
vector control: in silico approach. Asian J Biomed Pharm Sci. 2014;4:25.
 22. Darriet F, Chandre F. Efficacy of six neonicotinoid insecticides alone 
and in combination with deltamethrin and piperonyl butoxide against 
pyrethroid-resistant Aedes aegypti and Anopheles gambiae (Diptera: Culici-
dae). Pest Manag Sci. 2013;69:905–10.
 23. WHO. Recommended long-lasting insecticidal nets. Geneva: World 
Health Organization; 2017. p. 1–2.
 24. WHO. WHO prequalifies indoor residual spray for vector control. Geneva: 
World Health Organization; 2017.
 25. Bayer. Fludora fusion [Internet]. https ://www.vecto rcont rol.bayer .com/
solut ions/produ cts/fludo ra-fusio n. Accessed 17 Feb 2019.
 26. Darriet F, Chandre F. Combining piperonyl butoxide and dinotefuran 
restores the efficacy of deltamethrin mosquito nets against resistant 
Anopheles gambiae (Diptera: Culicidae). J Med Entomol. 2011;48:952–5.
 27. Ngufor C, Fongnikin A, Rowland M, N’Guessan R. Indoor residual spraying 
with a mixture of clothianidin (a neonicotinoid insecticide) and del-
tamethrin provides improved control and long residual activity against 
pyrethroid resistant Anopheles gambiae s.l. in Southern Benin. PLoS ONE. 
2017;12:e0189575.
 28. Uragayala S, Kamaraju R, Tiwari SN, Sreedharan S, Ghosh SK, Valecha N. 
Village-scale (Phase III) evaluation of the efficacy and residual activity of 
 SumiShield®50 WG (Clothianidin 50%, w/w) for indoor spraying for the 
control of pyrethroid-resistant Anopheles culicifacies Giles in Karnataka 
state, India. Trop Med Int Health. 2018;23:605–15.
 29. Messenger LA, Shililu J, Irish SR, Anshebo GY, Tesfaye AG, Ye-ebiyo Y, et al. 
Insecticide resistance in Anopheles arabiensis from Ethiopia (2012–2016): 
a nationwide study for insecticide resistance monitoring. Malar J. 
2017;16:469.
 30. Centers for Disease Control and Prevention. Guideline for evaluating 
insecticide resistance in vectors using the CDC bottle bioassay. CDC 
Methods. 2012;1–28.
 31. Balkew M, Ibrahim M, Koekemoer LL, Brooke BD, Engers H, Aseffa A, et al. 
Insecticide resistance in Anopheles arabiensis (Diptera: Culicidae) from 
villages in central, northern and south west Ethiopia and detection of kdr 
mutation. Parasit Vectors. 2010;3:40.
 32. (AIRS) PI. Africa Indoor Residual Spraying Project Ethiopia Entomological 
Monitoring Final Report, 2017. 2017.
 33. Morgan JC, Irving H, Okedi LM, Steven A, Wondji CS. Pyrethroid resist-
ance in an Anopheles funestus population from Uganda. PLoS ONE. 
2010;5:e11872.
 34. Gillies MT, Coetzee M. A supplement to the Anophelinae of Africa south 
of the Sahara (Afrotropical Region). Publ South African Inst Med Res. 
1987.
 35. Bashalkhanov S, Pandey M, Rajora OP. A simple method for estimating 
genetic diversity in large populations from finite sample sizes. BMC 
Genet. 2009;10:84.
 36. WHO Test procedures for insecticide resistance monitoring in malaria 
vector mosquitoes. World Health Organ Tech Rep Ser. 2013;22.
 37. Bates D, Machler M, Bolker B, Walker S. Fitting linear mixed-effects models 
using lme4. J Stat Softw. 2015;67(1):1–48.
Page 11 of 11Dagg et al. Malar J           (2019) 18:49 
•
 
fast, convenient online submission
 •
  
thorough peer review by experienced researchers in your field
• 
 
rapid publication on acceptance
• 
 
support for research data, including large and complex data types
•
  
gold Open Access which fosters wider collaboration and increased citations 
 
maximum visibility for your research: over 100M website views per year •
  At BMC, research is always in progress.
Learn more biomedcentral.com/submissions
Ready to submit your research ?  Choose BMC and benefit from: 
 38. R Core Team. R: a language and environment for statistical computing. 
Vienna: R Foundation for Statistical Computing. 2018. https ://www.R-
proje ct.org/.
 39. Corbel V, Duchon S, Zaim M, Hougard J. Dinotefuran: a potential 
neonicotinoid insecticide against resistant mosquitoes. J Med Entomol. 
2004;41:712–7.
 40. Uragayala S, Verma V, Natarajan E, Velamuri PS, Kamaraju R. Adulticidal & 
larvicidal efficacy of three neonicotinoids against insecticide susceptible 
& resistant mosquito strains. Indian J Med Res. 2015;142:64–70.
 41. Alemayehu E, Asale A, Eba K, Getahun K, Tushune K, Bryon A, et al. Map-
ping insecticide resistance and characterization of resistance mecha-
nisms in Anopheles arabiensis (Diptera: Culicidae) in Ethiopia. Parasit 
Vectors. 2017;10:407.
 42. Ngufor C, Guessan RN, Boko P, Odjo A, Vigninou E, Asidi A, et al. Combin-
ing indoor residual spraying with chlorfenapyr and long-lasting insec-
ticidal bed nets for improved control of pyrethroid-resistant Anopheles 
gambiae: an experimental hut trial in Benin. Malar J. 2011;10:343.
 43. Oliver SV, Kaiser ML, Wood OR, Coetzee M, Rowland M, Brooke BD. Evalu-
ation of the pyrrole insecticide chlorfenapyr against pyrethroid resistant 
and susceptible Anopheles funestus (Diptera: Culicidae). Trop Med Int 
Health. 2010;15:127–31.
 44. Bayili K, N’do S, Namountougou M, Sanou R, Ouattara A, Dabiré RK, et al. 
Evaluation of efficacy of  Interceptor® G2, a long-lasting insecticide net 
coated with a mixture of chlorfenapyr and alpha-cypermethrin, against 
pyrethroid resistant Anopheles gambiae s.l. in Burkina Faso. Malar J. 
2017;16:190.
 45. Ngufor C, Fagbohoun J, Critchley J, N’Guessan R, Todjinou D, Malone D, 
et al. Which intervention is better for malaria vector control: insecticide 
mixture long-lasting insecticidal nets or standard pyrethroid nets com-
bined with indoor residual spraying? Malar J. 2017;16:340.
 46. N’Guessan R, Odjo A, Ngufor C, Malone D, Rowland M. A chlorfenapyr 
mixture net  interceptor® G2 shows high efficacy and wash durability 
against resistant mosquitoes in West Africa. PLoS ONE. 2016;11:e0165925.
 47. Verma V, Elamathi N, Velamuri PS, Sreehari U, Agrawal OP, Raghavendra K. 
Chlorfenapyr: irritant effect compared to other insecticides and its intrin-
sic toxicity in multiple-insecticide-susceptible and -resistant Anopheles 
stephensi (Diptera: Culicidae). J Vector Borne Dis. 2015;52:99–103.
 48. Raghavendra K, Barik TK, Bhatt RM, Srivastava HC, Sreehari U, Dash AP. 
Evaluation of the pyrrole insecticide chlorfenapyr for the control of Culex 
quinquefasciatus Say. Acta Trop. 2011;118:50–5.
 49. Yuan JZ, Li QF, Huang JB, Gao JF. Effect of chlorfenapyr on cypermethrin-
resistant Culex pipiens pallens Coq mosquitoes. Acta Trop. 2015;143:13–7.
 50. Donnelly M, Isaacs A, Weetman D. Identification, validation, and applica-
tion of molecular diagnostics for insecticide resistance in malaria vectors. 
Trends Parasitol. 2016;32:197–206.
 51. Oxborough RM, N’Guessan R, Jones R, Kitau J, Ngufor C, Malone D, et al. 
The activity of the pyrrole insecticide chlorfenapyr in mosquito bioassay: 
towards a more rational testing and screening of non-neurotoxic insecti-
cides for malaria vector control. Malar J. 2015;14:124.
 52. Read AF, Lynch PA, Thomas MB. How to make evolution-proof insecti-
cides for malaria control. PLoS Biol. 2009;7:e1000058.
